LUPUS
Clinical trials for LUPUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS trials appear
Sign up with your email to follow new studies for LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lupus drug candidate BMS-986326 enters early human testing
Disease control CompletedThis early-phase study tested a new drug called BMS-986326 in 45 adults with different forms of lupus, including skin and systemic lupus. The main goal was to check safety and how the body processes the drug, not yet to see if it works. Participants received either the drug or a …
Matched conditions: LUPUS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lupus pain drug shows promise in early trial
Symptom relief CompletedThis phase 2 study tested whether JBT-101 (lenabasum) can reduce joint pain in people with systemic lupus erythematosus (SLE). 109 adults with active arthritis and at least moderate pain took either the drug or a placebo for 84 days. The main goal was to see if pain scores improv…
Matched conditions: LUPUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Lupus patients speak out: new study reveals daily struggles
Knowledge-focused CompletedThis study asked 88 Canadian adults with lupus about their quality of life, work productivity, and treatment preferences. Researchers used questionnaires to capture the real-world burden of the disease. The goal is to help doctors and policymakers better support people living wit…
Matched conditions: LUPUS
Sponsor: PeriPharm • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC